Undiscovered Gems in Middle East Featuring Gulf Pharmaceutical Industries P.S.C and 2 Promising Small Caps

Simply Wall St

As Gulf stocks rally on earnings optimism and investor enthusiasm, the Middle East market is capturing attention with selective buying ahead of key corporate results and a stable U.S. Federal Reserve outlook. In this dynamic environment, identifying promising small-cap stocks like Gulf Pharmaceutical Industries P.S.C., alongside other emerging players, can offer unique opportunities for investors seeking to capitalize on regional economic resilience and strategic growth potential.

Top 10 Undiscovered Gems With Strong Fundamentals In The Middle East

NameDebt To EquityRevenue GrowthEarnings GrowthHealth Rating
Baazeem Trading8.48%-2.02%-2.70%★★★★★★
Saudi Azm for Communication and Information Technology1.94%16.33%21.26%★★★★★★
MOBI Industry6.50%5.60%24.00%★★★★★★
Sure Global TechNA11.95%18.65%★★★★★★
Nofoth Food ProductsNA15.75%27.63%★★★★★★
Etihad Atheeb Telecommunication1.05%36.24%62.23%★★★★★★
Najran Cement14.20%-2.87%-22.60%★★★★★★
National General Insurance (P.J.S.C.)NA14.55%29.05%★★★★★☆
National Corporation for Tourism and Hotels19.25%0.67%4.89%★★★★☆☆
Saudi Chemical Holding79.49%16.57%44.01%★★★★☆☆

Click here to see the full list of 224 stocks from our Middle Eastern Undiscovered Gems With Strong Fundamentals screener.

Here we highlight a subset of our preferred stocks from the screener.

Gulf Pharmaceutical Industries P.S.C (ADX:JULPHAR)

Simply Wall St Value Rating: ★★★★★☆

Overview: Gulf Pharmaceutical Industries P.S.C. operates in the manufacturing and sale of medicines, drugs, and various pharmaceutical, cosmetic, and medical compounds across the United Arab Emirates, other GCC countries, and internationally with a market capitalization of AED1.66 billion.

Operations: The company's primary revenue streams include its Manufacturing segment, generating AED864.90 million, and the Planet segment, contributing AED732.90 million.

Gulf Pharmaceutical Industries, known for its nimble market presence, has shown a commendable turnaround by becoming profitable this year. The company's net debt to equity ratio stands at a satisfactory 4.8%, reflecting sound financial management. Over the past five years, its debt to equity ratio improved significantly from 117% to 55.9%. Recent earnings reveal robust growth with sales reaching AED 359 million in Q1 2025, up from AED 337 million the previous year, and net income soaring to AED 141 million from just AED 2 million. Despite these gains, interest payments remain inadequately covered at only 1.4x EBIT coverage.

ADX:JULPHAR Earnings and Revenue Growth as at Jul 2025

Logo Yazilim Sanayi ve Ticaret (IBSE:LOGO)

Simply Wall St Value Rating: ★★★★★☆

Overview: Logo Yazilim Sanayi ve Ticaret A.S. develops and markets software solutions in Turkey and internationally, with a market capitalization of TRY14.72 billion.

Operations: Logo Yazilim generates revenue primarily from the software industry, amounting to TRY4.20 billion. The company's financials reflect a focus on this sector as its main revenue stream.

Logo Yazilim, a nimble player in the software industry, has shown impressive financial resilience. Its earnings surged by 314% last year, outpacing the industry's 22% growth. The company's debt-to-equity ratio plummeted from 32.5% to just 0.05% over five years, highlighting its strong balance sheet management. With more cash than total debt and a price-to-earnings ratio of 13.5x below the market's average of 19.8x, Logo presents an attractive valuation proposition for investors seeking growth potential in emerging markets like Turkey's software sector. Recent first-quarter results revealed TRY1 billion in sales and TRY730 million net income compared to a loss previously reported.

IBSE:LOGO Earnings and Revenue Growth as at Jul 2025

Urbanica (Palo) Retail (TASE:URBC)

Simply Wall St Value Rating: ★★★★★☆

Overview: Urbanica (Palo) Retail Ltd focuses on designing, purchasing, marketing, and retailing clothing for women, men, and children in Israel with a market cap of ₪1.48 billion.

Operations: Urbanica generates revenue primarily from fashion clothing and accessories, with the former contributing ₪487.01 million and the latter ₪132.95 million.

Urbanica Retail, a small cap player in the Middle East's retail sector, showcases impressive financial health with zero debt and positive free cash flow. Over the past year, its earnings surged by 69%, outpacing the Specialty Retail industry's 61% growth rate. Despite generating less than US$1 million in revenue, Urbanica's high-quality earnings highlight its operational efficiency. Recent activities include an upcoming special shareholders meeting on July 15, 2025. While future prospects remain promising given its robust performance metrics and strategic focus on profitability, investors should weigh these strengths against its modest revenue scale.

TASE:URBC Earnings and Revenue Growth as at Jul 2025

Key Takeaways

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Gulf Pharmaceutical Industries P.S.C might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com